カテゴリ： Allied Market Research, 世界, 医療/バイオ

牛乳房炎のグローバル市場（2020～2030）：抗生物質、その他

■ 英語タイトル：Bovine Mastitis Market By Product (Antibiotics, Other), By Route of administration (Intramammary, Systemic), By Application (Veterinary Hospitals and Clinics, On-site Treatment): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート（データ管理コード：ALD23JN085）■ 発行会社/調査会社：Allied Market Research
■ 商品コード：ALD23JN085
■ 発行日：2022年9月
■ 調査対象地域：グローバル
■ 産業分野：生命科学
■ ページ数：300
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[牛乳房炎のグローバル市場（2020～2030）：抗生物質、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Allied Market Research社の本レポートでは、2021年に5.4億ドルであった世界の牛乳房炎市場規模が2031年には1,006.44百万ドルに達し、2022年から2031年にかけて年平均6.3％成長すると予測しています。Allied Market Research社の本レポートでは、世界の牛乳房炎市場について幅広く調査し、イントロダクション、エグゼクティブサマリー、市場概要、製品別分析（抗生物質、その他）、投与経路別分析（乳房内、全身）、用途別分析（動物病院＆診療所、オンサイト治療）、地域別分析（北米、ヨーロッパ、アジア太平洋、中南米/中東・アフリカ）、企業状況、企業情報など、以下の内容を掲載しています。さらに、Armenta Ltd.、Boehringer Ingelheim Gmbh、Ecolab Inc.、Forte Healthcare Ltd.、Huvepharma nv、Merck KGaA、Mileutis Ltd、Neogen Corporation、Thermo Fisher Scientific Inc、Zoetis Inc.などの企業情報が含まれています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の牛乳房炎市場規模：製品別分析
- 抗生物質の市場規模
- その他製品の市場規模
・世界の牛乳房炎市場規模：投与経路別分析
- 乳房内投与の市場規模
- 全身投与の市場規模
・世界の牛乳房炎市場規模：用途別分析
- 動物病院＆診療所における市場規模
- オンサイト治療における市場規模
・世界の牛乳房炎市場規模：地域別分析
- 北米の牛乳房炎市場規模
- ヨーロッパの牛乳房炎市場規模
- アジア太平洋の牛乳房炎市場規模
- 中南米/中東・アフリカの牛乳房炎市場規模
・企業状況
・企業情報

世界の牛乳房炎市場の2021年の市場規模は5億4,000万ドルと評価され、2022年から2031年まで年平均成長率6.3%で成長して2031年には10億6,644万ドルに達すると予測されています。
牛乳房炎は、微生物感染または物理的損傷によって引き起こされる乳腺の乳房組織の炎症反応です。生産高の減少や乳質の低下により、酪農部門に経済的損失をもたらす最も一般的な病気とされています。
牛乳房炎の発生件数の増加と動物の感染症の増加が市場の成長を後押ししています。例えば、科学・技術・医学分野の学術雑誌・書籍の世界的大手出版社であるIntechOpenが2020年に発表した論文によると、牛の潜在性乳房炎の有病率は全体で31.55%でした。潜在性乳房炎の有病率は、5 ～ 7 歳の年齢層で最も高く（38.50%）。このように、牛乳房炎とそれに関連する感染症の急増が市場の成長を牽引しています。

さらに、牛乳房炎に対する意識の高まりや、獣医療に対する関心の高まりも市場の成長に寄与しています。牛乳房炎は、エリスロマイシンやタイロシンなどの抗生物質で治療できます。乳房炎は、衛生状態の維持、適切に機能する搾乳機の使用、清潔で乾燥した快適な飼育場所の維持、持続的に感染している動物の隔離と淘汰、乾乳牛の抗生物質療法によって予防することができます。
さらに、乳製品需要の増加や、牛や水牛などの搾乳頭数の増加といった要因も、市場の成長を後押ししています。例えば、世界的な経営コンサルティング会社であるMcKinsey & Companyの調査によると、パンデミック流行前と比較して2020年には、乳製品を主にオンラインで購入すると回答した米国の乳製品消費者が163%増加します。このように、乳製品に対する需要の高まりが市場の成長に寄与しています。

さらに、先進的な牛乳房炎治療薬の開発のための研究開発活動の増加、米国食品医薬品局（FDA）の承認の増加、主要企業による市場での新規製品の発売が市場の成長を後押ししています。例えば、2020年2月、水、食品衛生、健康技術およびサービスの世界的リーダーであるEcolab社は、感染症を予防し、乳頭の健康を改善し、乳質をサポートする乳牛用の効果的で手頃な乳房ケアソリューションであるエコフレックス乳頭ディップを発表しました。さらに、牛の健康状態を評価する人工知能（AI）ベースのツールの統合など、牛乳房炎に関する進歩が市場の成長にさらに貢献しています。しかし、牛の抗生物質耐性や牛乳房炎国に対する認識不足は、市場の成長を妨げる可能性があります。抗生物質の繰り返しの使用により、細菌や真菌は、それらを殺すために設計された薬剤を打ち負かす能力を開発し、この現象は抗生物質耐性と呼ばれています。

牛乳房炎市場は、製品、投与経路、エンドユーザー、地域によって区分されます。
製品別では、市場は抗生物質とその他に分けられます。
投与経路別では、市場は乳房内投与と全身投与に分類されます。
エンドユーザー別では、市場は動物病院＆クリニック、オンサイト治療に分類されます。
地域別では、北米、欧州、アジア太平洋、LAMEAに市場を分けて分析しています。

本レポートに掲載されている主要企業は、Armenta Ltd.、Boehringer Ingelheim GmbH、Ecolab Inc.、Forte Healthcare Ltd.、Huvepharma NV、Merck KGaA、Mileutis Ltd.、Neogen Corporation、Thermo Fisher Scientific Inc.、Zoetis Inc.などです。

〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までの牛乳房炎市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、優勢な牛乳房炎市場機会を特定します。
・主な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・牛乳房炎市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・地域別および世界の牛乳房炎市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
製品別
抗生物質
その他

投与経路別
乳房内
全身投与

用途別
動物病院＆クリニック
訪問診療

地域別
・北米
アメリカ
カナダ
メキシコ
・ヨーロッパ
フランス
ドイツ
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
日本
中国
インド
オーストラリア
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
トルコ
その他のLAMEA地域

〈主要市場プレイヤー〉
Armenta Ltd.
Boehringer Ingelheim Gmbh
Ecolab Inc.
Forte Healthcare Ltd.
Huvepharma nv
Merck KGaA
Mileutis Ltd
Neogen Corporation
Thermo Fisher Scientific Inc
Zoetis Inc.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: BOVINE MASTITIS MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Antibiotics
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Other
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Intramammary
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Systemic
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: BOVINE MASTITIS MARKET, BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Veterinary Hospitals and Clinics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.2.4 Veterinary Hospitals and Clinics Bovine Mastitis Market by Cases
6.2.4.1 Mild Cases Market size and forecast, by region
6.2.4.2 Moderate Cased Market size and forecast, by region
6.2.4.3 Severe Cases Market size and forecast, by region
6.3 On-site Treatment
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.3.4 On-site Treatment Bovine Mastitis Market by Cases
6.3.4.1 Mild Cases Market size and forecast, by region
6.3.4.2 Moderate Cases Market size and forecast, by region
6.3.4.3 Severe Cases Market size and forecast, by region
CHAPTER 7: BOVINE MASTITIS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.3 North America Market size and forecast, by Route of administration
7.2.4 North America Market size and forecast, by Application
7.2.4.1 North America Veterinary Hospitals and Clinics Bovine Mastitis Market by Cases
7.2.4.2 North America On-site Treatment Bovine Mastitis Market by Cases
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Route of administration
7.2.5.1.3 Market size and forecast, by Application
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Route of administration
7.2.5.2.3 Market size and forecast, by Application
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Route of administration
7.2.5.3.3 Market size and forecast, by Application
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.3 Europe Market size and forecast, by Route of administration
7.3.4 Europe Market size and forecast, by Application
7.3.4.1 Europe Veterinary Hospitals and Clinics Bovine Mastitis Market by Cases
7.3.4.2 Europe On-site Treatment Bovine Mastitis Market by Cases
7.3.5 Europe Market size and forecast, by country
7.3.5.1 France
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Route of administration
7.3.5.1.3 Market size and forecast, by Application
7.3.5.2 Germany
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Route of administration
7.3.5.2.3 Market size and forecast, by Application
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Route of administration
7.3.5.3.3 Market size and forecast, by Application
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Route of administration
7.3.5.4.3 Market size and forecast, by Application
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product
7.3.5.5.2 Market size and forecast, by Route of administration
7.3.5.5.3 Market size and forecast, by Application
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product
7.3.5.6.2 Market size and forecast, by Route of administration
7.3.5.6.3 Market size and forecast, by Application
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.3 Asia-Pacific Market size and forecast, by Route of administration
7.4.4 Asia-Pacific Market size and forecast, by Application
7.4.4.1 Asia-Pacific Veterinary Hospitals and Clinics Bovine Mastitis Market by Cases
7.4.4.2 Asia-Pacific On-site Treatment Bovine Mastitis Market by Cases
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Route of administration
7.4.5.1.3 Market size and forecast, by Application
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Route of administration
7.4.5.2.3 Market size and forecast, by Application
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Route of administration
7.4.5.3.3 Market size and forecast, by Application
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Route of administration
7.4.5.4.3 Market size and forecast, by Application
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Route of administration
7.4.5.5.3 Market size and forecast, by Application
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Product
7.4.5.6.2 Market size and forecast, by Route of administration
7.4.5.6.3 Market size and forecast, by Application
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.3 LAMEA Market size and forecast, by Route of administration
7.5.4 LAMEA Market size and forecast, by Application
7.5.4.1 LAMEA Veterinary Hospitals and Clinics Bovine Mastitis Market by Cases
7.5.4.2 LAMEA On-site Treatment Bovine Mastitis Market by Cases
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Route of administration
7.5.5.1.3 Market size and forecast, by Application
7.5.5.2 Turkey
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Route of administration
7.5.5.2.3 Market size and forecast, by Application
7.5.5.3 Rest of LAMEA
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Route of administration
7.5.5.3.3 Market size and forecast, by Application
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Armenta Ltd.
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Boehringer Ingelheim Gmbh
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Ecolab Inc.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Forte Healthcare Ltd.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Huvepharma nv
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Merck KGaA
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Mileutis Ltd
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Neogen Corporation
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Thermo Fisher Scientific Inc
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Zoetis Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 2. BOVINE MASTITIS MARKET, FOR ANTIBIOTICS, BY REGION, 2021-2031 ($MILLION)
TABLE 3. BOVINE MASTITIS MARKET FOR ANTIBIOTICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. BOVINE MASTITIS MARKET, FOR OTHER, BY REGION, 2021-2031 ($MILLION)
TABLE 5. BOVINE MASTITIS MARKET FOR OTHER, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. GLOBAL BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 7. BOVINE MASTITIS MARKET, FOR INTRAMAMMARY, BY REGION, 2021-2031 ($MILLION)
TABLE 8. BOVINE MASTITIS MARKET FOR INTRAMAMMARY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 9. BOVINE MASTITIS MARKET, FOR SYSTEMIC, BY REGION, 2021-2031 ($MILLION)
TABLE 10. BOVINE MASTITIS MARKET FOR SYSTEMIC, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 11. GLOBAL BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 12. BOVINE MASTITIS MARKET, FOR VETERINARY HOSPITALS AND CLINICS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. BOVINE MASTITIS MARKET FOR VETERINARY HOSPITALS AND CLINICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 14. GLOBAL VETERINARY HOSPITALS AND CLINICS BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 15. BOVINE MASTITIS MARKET, FOR MILD CASES, BY REGION, 2021-2031 ($MILLION)
TABLE 16. BOVINE MASTITIS MARKET, FOR MODERATE CASED, BY REGION, 2021-2031 ($MILLION)
TABLE 17. BOVINE MASTITIS MARKET, FOR SEVERE CASES, BY REGION, 2021-2031 ($MILLION)
TABLE 18. BOVINE MASTITIS MARKET, FOR ON-SITE TREATMENT, BY REGION, 2021-2031 ($MILLION)
TABLE 19. BOVINE MASTITIS MARKET FOR ON-SITE TREATMENT, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 20. GLOBAL ON-SITE TREATMENT BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 21. BOVINE MASTITIS MARKET, FOR MILD CASES, BY REGION, 2021-2031 ($MILLION)
TABLE 22. BOVINE MASTITIS MARKET, FOR MODERATE CASES, BY REGION, 2021-2031 ($MILLION)
TABLE 23. BOVINE MASTITIS MARKET, FOR SEVERE CASES, BY REGION, 2021-2031 ($MILLION)
TABLE 24. BOVINE MASTITIS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 25. NORTH AMERICA BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 26. NORTH AMERICA BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 27. NORTH AMERICA BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 28. NORTH AMERICA VETERINARY HOSPITALS AND CLINICS BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 29. NORTH AMERICA ON-SITE TREATMENT BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 30. NORTH AMERICA BOVINE MASTITIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 31. U.S. BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 32. U.S. BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 33. U.S. BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 34. CANADA BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 35. CANADA BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 36. CANADA BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 37. MEXICO BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 38. MEXICO BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 39. MEXICO BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 40. EUROPE BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 41. EUROPE BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 42. EUROPE BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 43. EUROPE VETERINARY HOSPITALS AND CLINICS BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 44. EUROPE ON-SITE TREATMENT BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 45. EUROPE BOVINE MASTITIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 46. FRANCE BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 47. FRANCE BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 48. FRANCE BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 49. GERMANY BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 50. GERMANY BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 51. GERMANY BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 52. UK BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 53. UK BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 54. UK BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 55. ITALY BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 56. ITALY BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 57. ITALY BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 58. SPAIN BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 59. SPAIN BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 60. SPAIN BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 61. REST OF EUROPE BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 62. REST OF EUROPE BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 63. REST OF EUROPE BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 64. ASIA-PACIFIC BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 65. ASIA-PACIFIC BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC VETERINARY HOSPITALS AND CLINICS BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 68. ASIA-PACIFIC ON-SITE TREATMENT BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 69. ASIA-PACIFIC BOVINE MASTITIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 70. JAPAN BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 71. JAPAN BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 72. JAPAN BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 73. CHINA BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 74. CHINA BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 75. CHINA BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 76. INDIA BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 77. INDIA BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 78. INDIA BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 79. AUSTRALIA BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 80. AUSTRALIA BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 81. AUSTRALIA BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 82. SOUTH KOREA BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 83. SOUTH KOREA BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 84. SOUTH KOREA BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 85. REST OF ASIA-PACIFIC BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 86. REST OF ASIA-PACIFIC BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 87. REST OF ASIA-PACIFIC BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 88. LAMEA BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 89. LAMEA BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 90. LAMEA BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 91. LAMEA VETERINARY HOSPITALS AND CLINICS BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 92. LAMEA ON-SITE TREATMENT BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 93. LAMEA BOVINE MASTITIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 94. BRAZIL BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 95. BRAZIL BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 96. BRAZIL BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 97. TURKEY BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 98. TURKEY BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 99. TURKEY BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 100. REST OF LAMEA BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 101. REST OF LAMEA BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 102. REST OF LAMEA BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 103.ARMENTA LTD.: COMPANY SNAPSHOT
TABLE 104.ARMENTA LTD.: OPERATING SEGMENTS
TABLE 105.ARMENTA LTD.: PRODUCT PORTFOLIO
TABLE 106.ARMENTA LTD.: NET SALES,
TABLE 107.ARMENTA LTD.: KEY STRATERGIES
TABLE 108.BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT
TABLE 109.BOEHRINGER INGELHEIM GMBH: OPERATING SEGMENTS
TABLE 110.BOEHRINGER INGELHEIM GMBH: PRODUCT PORTFOLIO
TABLE 111.BOEHRINGER INGELHEIM GMBH: NET SALES,
TABLE 112.BOEHRINGER INGELHEIM GMBH: KEY STRATERGIES
TABLE 113.ECOLAB INC.: COMPANY SNAPSHOT
TABLE 114.ECOLAB INC.: OPERATING SEGMENTS
TABLE 115.ECOLAB INC.: PRODUCT PORTFOLIO
TABLE 116.ECOLAB INC.: NET SALES,
TABLE 117.ECOLAB INC.: KEY STRATERGIES
TABLE 118.FORTE HEALTHCARE LTD.: COMPANY SNAPSHOT
TABLE 119.FORTE HEALTHCARE LTD.: OPERATING SEGMENTS
TABLE 120.FORTE HEALTHCARE LTD.: PRODUCT PORTFOLIO
TABLE 121.FORTE HEALTHCARE LTD.: NET SALES,
TABLE 122.FORTE HEALTHCARE LTD.: KEY STRATERGIES
TABLE 123.HUVEPHARMA NV: COMPANY SNAPSHOT
TABLE 124.HUVEPHARMA NV: OPERATING SEGMENTS
TABLE 125.HUVEPHARMA NV: PRODUCT PORTFOLIO
TABLE 126.HUVEPHARMA NV: NET SALES,
TABLE 127.HUVEPHARMA NV: KEY STRATERGIES
TABLE 128.MERCK KGAA: COMPANY SNAPSHOT
TABLE 129.MERCK KGAA: OPERATING SEGMENTS
TABLE 130.MERCK KGAA: PRODUCT PORTFOLIO
TABLE 131.MERCK KGAA: NET SALES,
TABLE 132.MERCK KGAA: KEY STRATERGIES
TABLE 133.MILEUTIS LTD: COMPANY SNAPSHOT
TABLE 134.MILEUTIS LTD: OPERATING SEGMENTS
TABLE 135.MILEUTIS LTD: PRODUCT PORTFOLIO
TABLE 136.MILEUTIS LTD: NET SALES,
TABLE 137.MILEUTIS LTD: KEY STRATERGIES
TABLE 138.NEOGEN CORPORATION: COMPANY SNAPSHOT
TABLE 139.NEOGEN CORPORATION: OPERATING SEGMENTS
TABLE 140.NEOGEN CORPORATION: PRODUCT PORTFOLIO
TABLE 141.NEOGEN CORPORATION: NET SALES,
TABLE 142.NEOGEN CORPORATION: KEY STRATERGIES
TABLE 143.THERMO FISHER SCIENTIFIC INC: COMPANY SNAPSHOT
TABLE 144.THERMO FISHER SCIENTIFIC INC: OPERATING SEGMENTS
TABLE 145.THERMO FISHER SCIENTIFIC INC: PRODUCT PORTFOLIO
TABLE 146.THERMO FISHER SCIENTIFIC INC: NET SALES,
TABLE 147.THERMO FISHER SCIENTIFIC INC: KEY STRATERGIES
TABLE 148.ZOETIS INC.: COMPANY SNAPSHOT
TABLE 149.ZOETIS INC.: OPERATING SEGMENTS
TABLE 150.ZOETIS INC.: PRODUCT PORTFOLIO
TABLE 151.ZOETIS INC.: NET SALES,
TABLE 152.ZOETIS INC.: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 耳鼻咽喉科（ENT）疾患治療のグローバル市場（2020～2030）：抗生物質、抗炎症薬、その他
  • 結膜炎治療のグローバル市場（2020～2030）：抗生物質、抗ウイルス薬、抗アレルギー薬、人工涙液
  • 牛乳腺炎治療システムのグローバル市場2024-2028：抗生物質、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(ALD23JN085 )"牛乳房炎のグローバル市場（2020～2030）：抗生物質、その他" (英文：Bovine Mastitis Market By Product (Antibiotics, Other), By Route of administration (Intramammary, Systemic), By Application (Veterinary Hospitals and Clinics, On-site Treatment): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。